Back to Search
Start Over
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice
- Source :
- Open Forum Infectious Diseases
- Publication Year :
- 2021
-
Abstract
- The TANGO trial demonstrated the efficacy of lamivudine plus dolutegravir in virologically suppressed patients without previous virological failures (VFs). In this dataset from clinical practice investigating the impact of past nucleoside reverse-transcriptase inhibitor resistance on this strategy, the combination of M184V/I plus at least 1 thymidine analog-associated mutation significantly increased the risk of VF.
- Subjects :
- 0301 basic medicine
resistance-associated mutations
030106 microbiology
maintenance therapy
dolutegravir
HIV
lamivudine
Settore MED/17 - MALATTIE INFETTIVE
Nucleoside Reverse Transcriptase Inhibitor
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Maintenance therapy
Medicine
030212 general & internal medicine
business.industry
Brief Report
Lamivudine
Resistance mutation
Virology
Clinical Practice
AcademicSubjects/MED00290
Infectious Diseases
Oncology
chemistry
Dolutegravir
Thymidine
business
Nucleoside
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Open Forum Infectious Diseases
- Accession number :
- edsair.doi.dedup.....60a117cb669a8574430728e4eeea27cc